<DOC>
	<DOCNO>NCT00852215</DOCNO>
	<brief_summary>We seek evaluate long-term safety efficacy drug-eluting stent large vessel compare bare metal stent .</brief_summary>
	<brief_title>Do Cobalt Chrome Stent Paclitaxel-Eluting Stent Have Equivalent Clinical Result Non-Complex Lesion ?</brief_title>
	<detailed_description>Drug-eluting stent ( DES ) prove reduced restenosis rate dramatically compare bare metal stent ( BMS ) . However , long-term safety DES still uncertain . Recent meta-analysis show late stent thrombosis rate high DES group although overall mortality similar 2 group . The safety issue DES first suggest BASKET-LATE study , compare cobalt chromium alloy BMS ( VISIONÂ® , Guidant , USA ) sirolimus- paclitaxel-coated DES . The study show significantly high rate death myocardial infarction DES group 7 18 month procedure ( BMS 1.3 % , DES 4.9 % , p=0.01 ) . Moreover , benefit reduce target vessel revascularization find even possibility late harm patient treat DES large native vessel . We perform multicenter prospective randomize study compare paclitaxel-eluting stent cobalt chromium stent several year , originally see whether major adverse cardiac event significantly low DES compare thin-strut BMS non-complex lesion subset . In article , would like investigate 2-year clinical event DES BMS group .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cobalt</mesh_term>
	<criteria>Angiographically prove significant stenosis native coronary artery ( &gt; 50 % diameter stenosis ischemic symptom positive functional study , &gt; 70 % diameter stenosis without ischemic symptom positive functional study ) plan target lesion number = &lt; 2 reference diameter 2.75 4.0 mm lesion fully cover one 28 mm shorter stent unprotected leave main coronary disease 50 % stenosis plan leave main angioplasty ostial target lesion ( within 5 mm ostium ) angiographic evidence thrombus within target lesion calcify lesion successfully predilated instent restenosis multivessel intervention 2 lesion atherectomy plan stenting bifurcation lesion need side branch balloon stenting Severe leave ventricular dysfunction echocardiographic ejection fraction le 30 % STelevation myocardial infarction within precede 72 hour</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>Angioplasty , Transluminal , Percutaneous Coronary</keyword>
	<keyword>Paclitaxel-eluting stent</keyword>
	<keyword>Vision stent</keyword>
</DOC>